Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanouil Fokas

Showing results (111-120 of 158) with videos related to

Pageof 16
Sort By:
Frontiers in Oncology|September 3, 2019
Association of Polo-Like Kinase 3 and PhosphoT273 Caspase 8 Levels With Disease-Related Outcomes Among Cervical Squamous Cell Carcinoma Patients Treated With Chemoradiation and BrachytherapyMax Fleischmann, Daniel Martin, Samuel Peña-Llopis, et al.
Cancer Research|January 7, 2021
A Spatial and Functional Interaction of a Heterotetramer Survivin-DNA-PKcs Complex in DNA Damage ResponseÖmer Güllülü, Stephanie Hehlgans, Benjamin E Mayer, et al.
Radiation Oncology (London, England)|January 3, 2025
Optimising (re-)irradiation for locally recurrent head and neck cancer: impact of dose-escalation, salvage surgery, PEG tube and biomarkers on oncological outcomes-a single centre analysisJulia Katharina Schleifenbaum, Janis Morgenthaler, Shachi Jenny Sharma, et al.
Oncotarget|December 1, 2016
Long non-coding RNA urothelial carcinoma associated 1 (UCA1) mediates radiation response in prostate cancerAlireza Fotouhi Ghiam, Samira Taeb, Xiaoyong Huang, et al.
Journal of the National Cancer Institute|December 6, 2017
Tumor Regression Grading After Preoperative Chemoradiotherapy as a Prognostic Factor and Individual-Level Surrogate for Disease-Free Survival in Rectal CancerEmmanouil Fokas, Philipp Ströbel, Rainer Fietkau, et al.
International Journal of Radiation Oncology, Biology, Physics|November 12, 2013
Preoperative chemoradiation therapy with capecitabine/oxaliplatin and cetuximab in rectal cancer: long-term results of a prospective phase 1/2 studyEmmanouil Fokas, Lena Conradi, Christian Weiss, et al.
BMC Cancer|September 14, 2016
A phase-I trial of pre-operative, margin intensive, stereotactic body radiation therapy for pancreatic cancer: the 'SPARC' trial protocolDaniel L P Holyoake, Elizabeth Ward, Derek Grose, et al.
Cancer Research|August 3, 2017
Gemcitabine-Induced TIMP1 Attenuates Therapy Response and Promotes Tumor Growth and Liver Metastasis in Pancreatic CancerZenobia D'Costa, Keaton Jones, Abul Azad, et al.
Nature Reviews. Gastroenterology & Hepatology|March 15, 2024
Future direction of total neoadjuvant therapy for locally advanced rectal cancerYoshinori Kagawa, J Joshua Smith, Emmanouil Fokas, et al.
The Lancet. Oncology|May 4, 2020
Outcome measures in multimodal rectal cancer trialsEmmanouil Fokas, Robert Glynne-Jones, Ane Appelt, et al.
Pageof 16

Showing results (111-120 of 158) with videos related to

Sort By:
Pageof 16
Frontiers in Oncology|September 3, 2019
Association of Polo-Like Kinase 3 and PhosphoT273 Caspase 8 Levels With Disease-Related Outcomes Among Cervical Squamous Cell Carcinoma Patients Treated With Chemoradiation and BrachytherapyMax Fleischmann, Daniel Martin, Samuel Peña-Llopis, et al.
Cancer Research|January 7, 2021
A Spatial and Functional Interaction of a Heterotetramer Survivin-DNA-PKcs Complex in DNA Damage ResponseÖmer Güllülü, Stephanie Hehlgans, Benjamin E Mayer, et al.
Radiation Oncology (London, England)|January 3, 2025
Optimising (re-)irradiation for locally recurrent head and neck cancer: impact of dose-escalation, salvage surgery, PEG tube and biomarkers on oncological outcomes-a single centre analysisJulia Katharina Schleifenbaum, Janis Morgenthaler, Shachi Jenny Sharma, et al.
Oncotarget|December 1, 2016
Long non-coding RNA urothelial carcinoma associated 1 (UCA1) mediates radiation response in prostate cancerAlireza Fotouhi Ghiam, Samira Taeb, Xiaoyong Huang, et al.
Journal of the National Cancer Institute|December 6, 2017
Tumor Regression Grading After Preoperative Chemoradiotherapy as a Prognostic Factor and Individual-Level Surrogate for Disease-Free Survival in Rectal CancerEmmanouil Fokas, Philipp Ströbel, Rainer Fietkau, et al.
International Journal of Radiation Oncology, Biology, Physics|November 12, 2013
Preoperative chemoradiation therapy with capecitabine/oxaliplatin and cetuximab in rectal cancer: long-term results of a prospective phase 1/2 studyEmmanouil Fokas, Lena Conradi, Christian Weiss, et al.
BMC Cancer|September 14, 2016
A phase-I trial of pre-operative, margin intensive, stereotactic body radiation therapy for pancreatic cancer: the 'SPARC' trial protocolDaniel L P Holyoake, Elizabeth Ward, Derek Grose, et al.
Cancer Research|August 3, 2017
Gemcitabine-Induced TIMP1 Attenuates Therapy Response and Promotes Tumor Growth and Liver Metastasis in Pancreatic CancerZenobia D'Costa, Keaton Jones, Abul Azad, et al.
Nature Reviews. Gastroenterology & Hepatology|March 15, 2024
Future direction of total neoadjuvant therapy for locally advanced rectal cancerYoshinori Kagawa, J Joshua Smith, Emmanouil Fokas, et al.
The Lancet. Oncology|May 4, 2020
Outcome measures in multimodal rectal cancer trialsEmmanouil Fokas, Robert Glynne-Jones, Ane Appelt, et al.
Pageof 16